Stocktoria
Inspire Medical Systems, Inc. INSP
Inspire Medical Systems, Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $912.0M | $802.8M | $624.8M | $407.9M | $233.4M | $115.4M | $82.0M | $50.6M | $28.6M |
| Gross profit | $778.8M | $679.8M | $528.2M | $341.7M | $200.1M | $97.8M | $68.4M | $40.5M | $22.5M |
| R&D expense | $103.2M | $114.1M | $116.5M | $68.6M | $37.4M | $26.1M | $12.8M | $7.4M | $6.2M |
| SG&A expense | $624.6M | $529.6M | $452.0M | $320.7M | $202.6M | $127.9M | $90.5M | $53.5M | $32.4M |
| Operating income | $51.0M | $36.1M | -$40.3M | -$47.6M | -$39.9M | -$56.2M | -$34.9M | -$20.4M | -$16.0M |
| Interest expense | — | — | $0 | $1.7M | $2.1M | $2.1M | $2.1M | $3.3M | $1.8M |
| Income tax | -$79.7M | $4.9M | $1.2M | $613,000 | $72,000 | $115,000 | $40,000 | $0 | $0 |
| Net income | $145.4M | $53.5M | -$21.2M | -$44.9M | -$42.0M | -$57.2M | -$33.2M | -$21.8M | -$17.5M |
| EPS (diluted) | $4.89 | $1.75 | $-0.72 | $-1.60 | $-1.54 | $-2.19 | $-1.40 | — | — |
| Operating cash flow | $117.0M | $130.2M | $24.7M | $11.6M | -$20.1M | -$53.0M | -$32.8M | -$18.7M | -$15.8M |
| Free cash flow | $78.5M | $91.1M | $1.0M | $2.5M | -$24.8M | -$55.5M | -$35.6M | -$18.9M | -$16.2M |
| Cash & equivalents | $104.8M | $150.2M | $185.5M | $441.6M | $214.5M | $190.5M | $22.9M | $97.3M | $9.0M |
| Inventory | $145.3M | $80.1M | $33.9M | $11.9M | $17.2M | $8.5M | $5.8M | $2.7M | $3.7M |
| Total assets | $907.3M | $808.4M | $676.8M | $564.9M | $295.1M | $281.2M | $181.3M | $200.1M | $25.1M |
| Total liabilities | $126.2M | $118.7M | $104.3M | $68.9M | $66.0M | $51.4M | $41.4M | $36.1M | $23.8M |
| Shareholders' equity | $781.2M | $689.7M | $572.5M | $496.0M | $229.0M | $229.7M | $139.8M | $164.0M | $1.3M |
Growth · year-over-year · Revenue CAGR 54.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +13.6% | +28.5% | +53.2% | +74.7% | +102.3% | +40.6% | +62.2% | +77.1% | — |
| Net income growth | +171.8% | — | — | — | — | — | — | — | — |
| EPS growth | +179.4% | — | — | — | — | — | — | — | — |
| Free cash flow growth | -13.9% | +8798.7% | -58.6% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.